A T cell receptor associated with naturally occurring human tumor immunity Academic Article Article uri icon


MeSH Major

  • Myelodysplastic Syndromes
  • RNA-Binding Proteins


  • The onconeural antigens appear to serve as tumor rejection antigens in the paraneoplastic neurologic disorders. Here, we used an unbiased peptide binding screen, followed by studies in HLA-A2.1 transgenic mice to identify naturally processed HLA-A2.1 restricted epitopes of the paraneoplastic cerebellar degeneration breast/ovarian cancer antigen cdr2. These mice were used to clone high-avidity cdr2-specific CD8(+) T cells that recognize human tumor cells presenting endogenously loaded MHC class I-cdr2 peptide. T cells with this specificity were detected in the peripheral blood of two HLA-A2.1(+) paraneoplastic cerebellar degeneration patients. We cloned T cell receptor (TCR) alpha and beta genes from cdr2-specific T cells; electroporation of RNA encoding this TCR turned nonreactive donor T cells into efficient killers of human cdr2-expressing tumor cells. Cloned cdr2-specific TCR genes provide a clinically relevant means for immunologic targeting of human gynecologic cancers.

publication date

  • November 27, 2007



  • Academic Article


Digital Object Identifier (DOI)

  • 10.1073/pnas.0704336104

PubMed ID

  • 18045792

Additional Document Info

start page

  • 19073

end page

  • 8


  • 104


  • 48